Concepedia

Heather M. Froggatt

HM

6

Publications

575

Citations

6

H-Index

2020

Active since

Affiliations

Duke University(Current)

University of Vermont

University of Illinois Urbana-Champaign

Loyola University Chicago

Argonne National Laboratory

Heather M. Froggatt is an author at Duke University specializing in immunodominance, viral immunity, and vaccine development.

ORCID

Top concepts

Publications per year

2020–2023

6

Publications

6

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

Nir Drayman, Jennifer K. DeMarco, Krysten A. Jones et al. · Science · 2021 · 246 citations · Full text

Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL <sup>pro</sup> Reporter Assay

Heather M. Froggatt, Brook E. Heaton, Nicholas S. Heaton · Journal of Virology · 2020 · 110 citations · Full text

BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance

Audrey Lee, Katharine Floyd, Shengyang Wu et al. · Nature Immunology · 2023 · 78 citations · Full text

, , +11

GPER1 is required to protect fetal health from maternal inflammation

Alfred T. Harding, Marisa Goff, Heather M. Froggatt et al. · Science · 2021 · 61 citations · Full text

Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>

Nir Drayman, Krysten A. Jones, Saara‐Anne Azizi et al. · 2020 · 41 citations · Full text

Rows per page

1–5 of 6